Literature DB >> 34716910

Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers.

Erieta Kollari1, Ioanna Zografou2, Christos Sampanis2, Vasilios G Athyros2, Triantafyllos Didangelos3, Christos S Mantzoros4, Asterios Karagiannis2.   

Abstract

PURPOSE: The role of adipokines in causing inflammation and insulin resistance in normal weight and obese patients is generally well studied. However, there are often conflicting results regarding their levels in type 1 diabetes mellitus (T1DM) patients and their relationship to micro- and macrovascular disease. We therefore investigated which serum adipokine levels are independently associated with markers of early atherosclerosis and microvascular complications in patients with T1DM.
METHODS: A cross-sectional study was performed in the Diabetes Outpatient Clinic of Hippokrateion General Hospital, Thessaloniki, Greece. Sixty T1DM patients (30 females, mean age 38.8 ± 10.6 years, mean diabetes duration 17.4 ± 9.9 years) were included. Plasma adiponectin, leptin, and resistin, carotid artery intima media thickness (cIMT), and arterial stiffness (pulse wave velocity, PWV/SpygmoCor CP System and Mobil-O-Graph 24 h PWA) were assessed.
RESULTS: Leptin and resistin levels were significantly higher in overweight and obese patients (p = 0.002 and p = 0.039, respectively). Adiponectin was the only adipokine negatively correlated with BMI (rs =  - 0.41, p = 0.001). We report a bivariate association between serum adiponectin levels and retinopathy (p = 0.007). Resistin was the only adipokine that showed significant correlation with systolic (rs = 0.42, p = 0.001) and diastolic (rs = 0.29, p = 0.024) hypertension and PWV (p = 0.035).
CONCLUSIONS: Serum adipokine levels demonstrate similar bivariate associations with anthropometric variables in patients with T1DM to those in normal weight subjects. Although microvascular complications are associated with serum adipokine levels by bivariate analysis, only resistin, an inflammatory marker, is independently associated with arterial stiffness in patients with T1DM.
© 2021. Hellenic Endocrine Society.

Entities:  

Keywords:  Adiponectin; Leptin; PWV; Resistin; cIMT

Mesh:

Substances:

Year:  2021        PMID: 34716910     DOI: 10.1007/s42000-021-00328-9

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  39 in total

1.  Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion.

Authors:  Aldo V Greco; Gertrude Mingrone; Annalisa Giancaterini; Melania Manco; Manrico Morroni; Saverio Cinti; Marnie Granzotto; Roberto Vettor; Stefania Camastra; Ele Ferrannini
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

2.  How to interpret 24-h arterial stiffness markers: comparison of 24-h ambulatory Mobil-O-Graph with SphygmoCor office values.

Authors:  Andrius Berukstis; Jonas Jarasunas; Aurelija Daskeviciute; Ligita Ryliskyte; Arvydas Baranauskas; Rima Steponeniene; Aleksandras Laucevicius
Journal:  Blood Press Monit       Date:  2019-04       Impact factor: 1.444

Review 3.  The many faces of diabetes: a disease with increasing heterogeneity.

Authors:  Tiinamaija Tuomi; Nicola Santoro; Sonia Caprio; Mengyin Cai; Jianping Weng; Leif Groop
Journal:  Lancet       Date:  2013-12-03       Impact factor: 79.321

Review 4.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

5.  Leptin concentration in non-obese and obese children with type 1 diabetes mellitus.

Authors:  A Verrotti; F Basciani; M De Simone; G Morgese; F Chiarelli
Journal:  Biomed Pharmacother       Date:  2000-03       Impact factor: 6.529

6.  Insulin resistance is a risk factor for progression to type 1 diabetes.

Authors:  S Fourlanos; P Narendran; G B Byrnes; P G Colman; L C Harrison
Journal:  Diabetologia       Date:  2004-10-06       Impact factor: 10.122

Review 7.  Adipokines as a novel link between obesity and atherosclerosis.

Authors:  Hye Jin Yoo; Kyung Mook Choi
Journal:  World J Diabetes       Date:  2014-06-15

Review 8.  Overweight and obesity in youth with type 1 diabetes.

Authors:  Karl E Minges; Robin Whittemore; Margaret Grey
Journal:  Annu Rev Nurs Res       Date:  2013

9.  Serum leptin and adiponectin levels in children with type 1 diabetes mellitus - Relation to body fat mass and disease course.

Authors:  Katarzyna Anna Majewska; Dominik Majewski; Bogda Skowrońska; Witold Stankiewicz; Piotr Fichna
Journal:  Adv Med Sci       Date:  2015-11-03       Impact factor: 3.287

Review 10.  Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism.

Authors:  Hyeong-Kyu Park; Rexford S Ahima
Journal:  Metabolism       Date:  2014-08-15       Impact factor: 8.694

View more
  1 in total

1.  Alteration of Peripheral Resistin and the Severity of Acute Pancreatitis: A Meta-Analysis.

Authors:  Jianhua Yang; Mengyao Liu; Shu Wang; Yuanxiu Gan; Xiangyu Chen; Yang Tao; Junwei Gao
Journal:  Front Med (Lausanne)       Date:  2022-06-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.